Long-Term Clinical Benefits of Canagliflozin 100 mg Versus Sulfonylurea in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin in India.

Add to Collection

2019 May Others V Gupta, M Willis, P Johansen, A Nilsson… - Value in Health …, 2019 - Elsevier 54

Full Author : ['Gupta, Vishal', 'Willis, Michael', 'Johansen, Pierre', 'Nilsson, Andreas', 'Shah, Manan', 'Mane, Amey', 'Neslusan, Cheryl']
Journal Title : Value in health regional issues
Chapter : Section3
Journal Year : 2019
Cited by : 4.0

OBJECTIVES: To simulate the long-term health outcomes of canagliflozin 100 mg versus glimepiride over 20 years in patients with type 2 diabetes mellitus (T2DM) inadequately controlled on metformin from the perspective of the Indian health care system. MET..... Read More

Keywords : ["type diabetes mellitus inadequately control", "canagliflozin mg versus sulfonylurea", "longterm clinical benefit", "patient", "metformin", "india"]
PubMed Link : https://www.sciencedirect.com/science/article/pii/S2212109918301110
Google Scholar Link : https://scholar.google.com/scholar?cites=12823241915736230916&as_sdt=5,26&sciodt=0,26&hl=en&num=20

Have a Question?

Long-Term Clinical Benefits of Canagliflozin 100 mg Versus Sulfonylurea in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin in India.